ICD-10-PCS 2027 procedure code
XW0433AIntroduction of Bentracimab, Ticagrelor Reversal Agent into Central Vein, Percutaneous Approach, New Technology Group 10
Short description: Introduce Bentracimab in Central Vein, Perc, New Tech 10
Code last changed in FY2025 (effective October 1, 2024). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About XW0433A
XW0433A is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with bentracimab, ticagrelor reversal agent (qualifier: new technology group 10). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
For a different body part, codes include XW0333A (peripheral vein).
With a different device, use XW0434A (stem cells, somatic), XW0435A (ifezuntirgene inilparvovec), XW0438A (mineral-based topical hemostatic agent), XW0439A (odronextamab antineoplastic), XW043BA (vancomycin-eluting bone void filler), XW043CA (recombinant human bone morphogenetic protein-2 with collagen scaffold) and 3 more.
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It was added in FY2025, effective October 1, 2024.
What each character means
- 1. Section
- XNew Technology
- 2. Body System
- WAnatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body Part
- 4Central Vein
- 5. Approach
- 3Percutaneous
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
- 6. Device / Substance / Technology
- 3Bentracimab, Ticagrelor Reversal Agent
- 7. Qualifier
- ANew Technology Group 10
Other versions of this procedure
Different body part
Different device / substance / technology
- XW0434AStem Cells, Somatic
- XW0435AIfezuntirgene Inilparvovec
- XW0438AMineral-based Topical Hemostatic Agent
- XW0439AOdronextamab Antineoplastic
- XW043BAVancomycin-eluting Bone Void Filler
- XW043CARecombinant Human Bone Morphogenetic Protein-2 with Collagen Scaffold
- XW043FAOther New Technology Therapeutic Substance
- XW043MABaricitinib
- XW043NASER-109
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2025 (effective 10/1/2024): Added
- No changes since FY2025.
Common questions about XW0433A
Is XW0433A a valid ICD-10-PCS code for 2027?
- Yes. XW0433A is valid for inpatient procedures from October 1, 2026 through September 30, 2027.